Formulation
The most common formulation error is not ingredient selection. It is including a recognised ingredient at a level below the one the evidence supports, because the full dose would not fit the format, the cost target or the flavour system.
This produces a product that is technically honest and functionally inert. It also creates a regulatory problem, because a claim substantiated by a study at 600 mg does not transfer to a formula containing 150 mg. In Canada that surfaces as an information request. In markets without pre-market review it surfaces later, when someone asks for the substantiation.
Decide the efficacious dose first, then work outward to the format that can carry it. Reversing that order produces label decoration.
Each format carries its own failure modes, and choosing one commits you to them.
Capsules are forgiving on taste and unforgiving on volume. A formula requiring three grams of actives will not fit a capsule anyone wants to swallow.
Tablets accept higher loads but require compressible ingredients, and the binders and flow agents that make compression work add mass and can affect disintegration.
Powders accommodate large doses and expose every flavour problem you have. They also introduce blend uniformity risk, where a low-inclusion active can segregate during handling so that early and late servings differ.
Gummies are the least forgiving. The cook step degrades heat-sensitive actives, water activity drives both microbial risk and texture, and many actives simply taste too strong to mask at an efficacious dose.
Softgels and oils avoid taste problems and introduce oxidation as the dominant risk.
Liquids require preservation, and preservation systems interact with actives and pH in ways that are not always predictable.
Certain ingredient classes carry known degradation pathways, and knowing them at formulation stage is cheaper than discovering them at the twelve month pull.
Vitamin C, B vitamins and many botanicals are sensitive to moisture, heat and light. Probiotics lose viability over time, which means an overage calculated against the claim at end of shelf life rather than at manufacture. Unsaturated lipids oxidise, and the oxidation is driven by oxygen exposure, temperature, and the adequacy of the antioxidant system. Hygroscopic ingredients pull moisture through the packaging and change the physical properties of everything around them.
Water activity deserves particular attention because it governs both microbial growth and physical stability, and a formula sitting just below a threshold at manufacture can cross it during distribution.
Container closure selection is often treated as a branding decision made after the formula is locked. It belongs in the formulation conversation.
Barrier properties, moisture and oxygen transmission rates, headspace volume, closure integrity and light protection all affect the degradation pathways above. A formula that is stable in an amber glass bottle with an induction seal may not be stable in a clear PET jar with a screw cap, and the stability data generated in one does not support the other.
For any product a consumer tastes, sensory performance determines repeat purchase regardless of how good the formula is. It also carries stability information the analytical panel does not.
Oxidation in a lipid product is detectable by smell and taste before peroxide value and anisidine value reach their limits. Flavour systems drift. Colours fade. Textures change, and a gummy that develops cold flow or sticking has failed commercially even if it still meets every chemical specification.
Sensory evaluation belongs in the stability protocol alongside the analytical tests, assessed at each pull point by a structured panel rather than by whoever is available.
Bench top behaviour does not predict production behaviour reliably. A powder that flows in a laboratory blender can bridge in a production hopper. A blend that appears uniform in a two kilogram batch can segregate at five hundred. Compression behaviour changes with tooling and line speed.
Pilot scale work exists to surface these problems while changing course is still inexpensive. Skipping it saves weeks and regularly costs a full production run.